Lin Elizabeth Yeu

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 76% 68% 82%
Transactions
9 44% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 320%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Lin Elizabeth Yeu's trades of Tarsus Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
40.00
Quantity 2,500 +704.2%
Value US$100,000
Transaction date
Purchase
Price
16.80
Quantity 9,506 +149.5%
Value US$159,701
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-09 2026-09-04
PlS Planned sale
86,380 -9.5%
384.89
US$392,903 		86,380 -9.5% 384.89 US$392,903
2026-09-09 2026-09-04
PlS Planned sale
1,981 +46.8%
421.12
US$4,571,881 		1,981 +46.8% 421.12 US$4,571,881
2026-09-09 2026-09-04
PlS Planned sale
80,436 -40.6%
321.81
US$4,720,626 		80,436 -40.6% 321.81 US$4,720,626
2026-09-09 2026-09-04
PlS Planned sale
5,387 -40.4%
85.00
US$457,895 		5,387 -40.4% 85.00 US$457,895
2026-09-04 2026-09-04
PrS Proposed sale
3,180
87.50
US$278,250 		3,180 87.50 US$278,250
2026-09-04 2026-09-04
PrS Proposed sale
10,773
87.50
US$942,635 		10,773 87.50 US$942,635
2026-09-03 2026-09-02
PlS Planned sale
1,590 -25.0%
80.00
US$127,200 		1,590 -25.0% 80.00 US$127,200
2026-09-03 2026-09-02
PlS Planned sale
5,387 -28.8%
80.00
US$430,960 		5,387 -28.8% 80.00 US$430,960
2026-09-02 2026-09-02
PrS Proposed sale
1,590
80.00
US$127,200 		1,590 80.00 US$127,200
2026-09-02 2026-09-02
PrS Proposed sale
5,387
80.00
US$430,960 		5,387 80.00 US$430,960
2026-09-03 2026-09-01
PlS Planned sale
4,601 -19.7%
73.86
US$339,830 		4,601 -19.7% 73.86 US$339,830
2026-09-01 2026-09-01
PrS Proposed sale
4,601
73.86
US$339,830 		4,601 73.86 US$339,830
2026-03-19 2026-03-19
S Sale
390 -1.6%
67.00
US$26,130 		390 -1.6% 67.00 US$26,130
2026-03-19 2026-03-19
PrS Proposed sale
390
67.00
US$26,130 		390 67.00 US$26,130
2026-03-19 2026-03-18
S Sale
379 -1.6%
68.71
US$26,041 		379 -1.6% 68.71 US$26,041
2026-03-18 2026-03-18
PrS Proposed sale
379
68.71
US$26,041 		379 68.71 US$26,041
2026-03-19 2026-03-17
S Sale
375 -1.5%
69.42
US$26,032 		375 -1.5% 69.42 US$26,032
2026-03-17 2026-03-17
PrS Proposed sale
375
69.41
US$26,031 		375 69.41 US$26,031
2025-12-17 2025-12-16
S Sale
2,078 -8.7%
79.50
US$165,201 		2,078 -8.7% 79.50 US$165,201
2025-12-16 2025-12-16
PrS Proposed sale
2,078
79.50
US$165,202 		2,078 79.50 US$165,202
2025-06-17 2025-06-16
S Sale
1,006 -11.6%
41.08
US$41,326 		1,006 -11.6% 41.08 US$41,326
2025-06-16 2025-06-16
PrS Proposed sale
1,006
41.07
US$41,321 		1,006 41.07 US$41,321
2023-09-22 2023-09-21
B Purchase
2,500 +704.2%
40.00
US$100,000 		2,500 +704.2% 40.00 US$100,000
2023-08-17 2023-08-15
B Purchase
9,506 +149.5%
16.80
US$159,701 		9,506 +149.5% 16.80 US$159,701
2022-09-16 2022-09-14
B Purchase
6,360 +inf%
16.29
US$103,604 		6,360 +inf% 16.29 US$103,604
2022-09-16 2022-09-14
B Purchase
12,040 +inf%
16.03
US$193,001 		12,040 +inf% 16.03 US$193,001